Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhib…

Mechanistic description

Specific butyrate-producing gut bacteria (e.g., Faecalibacterium, Roseburia) generate systemic butyrate that crosses the blood-brain barrier and inhibits hippocampal microglial HDAC2, leading to hyperacetylation of transcription factors that upregulate TREM2-independent phagocytic pathways. This enhances microglial amyloid-beta uptake and lysosomal degradation while suppressing NLRP3 inflammasome activation. Testable prediction: Germ-free AD mice colonized with butyrate-producing bacteria or treated with sodium butyrate will show reduced amyloid plaque burden, increased microglial amyloid phagocytosis rates ex vivo, and decreased IL-1β and caspase-1 levels, compared to controls.

Mechanism / pathway

HDAC2
→
HDAC inhibition/microglial epigenetic reprogramming
→
Alzheimer's disease

Evidence for (5)

TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.

PMID:36306735 2022 Cell
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.

PMID:31932797 2020 Nat Med
TREM2, microglia, and Alzheimer's disease.

PMID:33516818 2021 Mech Ageing Dev
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.

PMID:28802038 2017 Cell
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.

PMID:28930663 2017 Immunity

Evidence against (1)

CNS effects of sodium butyrate require supraphysiological doses administered systemically (≥300 mg/kg in rodents) that gut-derived butyrate cannot achieve in CSF; colonocyte beta-oxidation and hepatic first-pass metabolism rapidly catabolize portal butyrate, leaving negligible concentrations to cross the BBB

PMID:33785315

Evidence matrix

5 supporting 1 contradicting

83% supporting

Supporting

TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways. PMID:36306735 · 2022 · Cell
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. PMID:31932797 · 2020 · Nat Med
TREM2, microglia, and Alzheimer's disease. PMID:33516818 · 2021 · Mech Ageing Dev
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. PMID:28802038 · 2017 · Cell
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. PMID:28930663 · 2017 · Immunity

Contradicting

CNS effects of sodium butyrate require supraphysiological doses administered systemically (≥300 mg/kg in rodents) that gut-derived butyrate cannot achieve in CSF; colonocyte beta-oxidation and hepatic first-pass metabolism rapidly catabolize portal butyrate, leaving negligible concentrations to cross the BBB PMID:33785315 · 10.3389/fncel.2021.631772

Cite this hypothesis

Citation

etl-backfill (2026). Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhib…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c7350d53bb

BibTeX

@misc{scidex_hypothesis_hc7350d5,
  title        = {Gut-derived butyrate reprograms microglia for amyloid clearance via HDAC2 inhib…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-c7350d53bb},
  note         = {SciDEX artifact hypothesis:h-c7350d53bb}
}